U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794346) titled 'Sexual Effects of Transdermal or Vaginal Testosterone' on March 18, 2022.
Brief Summary: The aim of the study is to elucidate the role of testosterone treatment in postmenopausal women's sexual function and their therapeutic safety.
Study Start Date: Oct. 01, 2020
Study Type: INTERVENTIONAL
Condition:
Female Sexual Dysfunction
Postmenopausal Symptoms
Testosterone Deficiency
Testosterone Adverse Reaction
Intervention:
DRUG: Transdermal testosterone
women will receive 300mcg of transdermal testosterone in cream daily for six months
DRUG: Vaginal testosterone gel
women will receive 300mcg of vaginal gel testosterone daily for ...